Back
Calvert US Mid-Cap Core Responsible Index ETF Vs. Akero Therapeutics Industry Stock Comparison
Buy
72
CVMC
Calvert US Mid-Cap Core Responsible Index ETF
Last Price:
$60.17
Seasonality Move:
2.4%
Sell
50
AKRO
Akero Therapeutics
Last Price:
$54.32
Seasonality Move:
30.3%
Buy
72
Calvert US Mid-Cap Core Responsible Index ETF (CVMC)
is a Buy
Is Calvert US Mid-Cap Core Responsible Index ETF a Buy, Sell or Hold?
-
The current Calvert US Mid-Cap Core Responsible Index ETF [CVMC] share price is $59.63. The Score for CVMC is 72, which is 44% above its historic median score of 50, and infers lower risk than normal.
-
CVMC is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
50
Akero Therapeutics (AKRO)
is a Sell
Is Akero Therapeutics a Buy, Sell or Hold?
-
The current Akero Therapeutics [AKRO] share price is $54.03. The Score for AKRO is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
-
AKRO is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CVMC Stock Price Chart
What is Calvert US Mid-Cap Core Responsible Index ETF's stock price today?
-
The Calvert US Mid-Cap Core Responsible Index ETF share price today is $59.63Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CVMC is experiencing buying pressure, which is a positive indicator for future bullish movement.
AKRO Stock Price Chart
What is Akero Therapeutics's stock price today?
-
The Akero Therapeutics share price today is $54.03The current trend is moderately bullish and AKRO is experiencing buying pressure, which is a positive indicator for future bullish movement.
CVMC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.38 | Buy |
Relative Strength Index (14 RSI): | 56.33 | Buy |
Chaikin Money Flow: | 698 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (58.83 - 59.93) | Buy |
Bollinger Bands (100): | (55.27 - 60.83) | Buy |
AKRO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.74 | Buy |
Relative Strength Index (14 RSI): | 62.21 | Buy |
Chaikin Money Flow: | 788305 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (45.84 - 55.48) | Buy |
Bollinger Bands (100): | (40.11 - 52.17) | Buy |
CVMC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 59.42 | Buy |
20-day SMA: | 59.37 | Buy |
50-day SMA: | 57.53 | Buy |
200-day SMA: | 59.38 | Buy |
8-day EMA: | 59.42 | Buy |
20-day EMA: | 59.23 | Buy |
50-day EMA: | 58.44 | Buy |
200-day EMA: | 58.22 | Buy |
AKRO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 54.55 | Sell |
20-day SMA: | 52.23 | Buy |
50-day SMA: | 45.56 | Buy |
200-day SMA: | 37.5 | Buy |
8-day EMA: | 54.31 | Sell |
20-day EMA: | 52.08 | Buy |
50-day EMA: | 47.87 | Buy |
200-day EMA: | 39.35 | Buy |
Calvert US Mid-Cap Core Responsible Index ETF Earnings Growth & CVMC Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Akero Therapeutics Earnings Growth & AKRO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.18 per share, and a decrease next year of $0.64 per share.
Calvert US Mid-Cap Core Responsible Index ETF Technical Analysis
Jun 9 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 16 | Jun 17 | Jun 18 | Jun 20 | Jun 23 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 20 | 23 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Akero Therapeutics Technical Analysis
Jun 9 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 16 | Jun 17 | Jun 18 | Jun 20 | Jun 23 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 20 | 23 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |